Donate

International Society for Molecular Neurodegeneration

ISMND Science Webinar Series: Philip C. Wong, Ph.D.

May 29, 2025 | 1:30–2:30 PM (ET) | An AAV gene therapy for ALS-FTD guided by a presymptomatic biomarker

More

ISMND Science Webinar Series: Malin Parmar, Ph.D.

EXCLUSIVE MEMBERS ONLY CONTENT | Developing a Stem Cell Based Therapy for Parkinson’s Disease

More

ISMND NextGen 2025

ISMND is delighted to announce that ‘ISMND NextGen 2025’ will be taking place virtually on August 25-26, 2025.

More

ISMND Science Webinar Series: Gilbert Di Paolo, Ph.D.

EXCLUSIVE MEMBERS ONLY CONTENT | Emerging pathogenic mechanisms for ApoE in Alzheimer’s disease as informed by studies of protective variants

More

ISMND Science Webinar Series: Inhee Mook-Jung, Ph.D.

February 20, 2025, 5pm (KST)/9am (CET) | Bypassing the BBB? The role of vagus nerves in the transmission of pathogenic molecules from gut to brain in Alzheimer’s disease

More

Early-career researcher in neurodegeneration?

Come share your research through a live oral presentation or a pre-recorded poster, connect with experts, and share ideas at ISMND NextGen 2025 – a dynamic virtual event!

Already completed your registration and wish to submit an abstract? CLICK HERE ➤

KEYNOTE SPEAKERS

• Renzo Mancuso, VIB, Belgium
• Miranda Orr, Ph.D, WashU, USA.

PANEL DISCUSSIONS

#1 ANTI-AMYLOID IMMUNOTHERAPY

• Bart de Strooper, KU Leuven, Belgium, UCL, UK
• Suzanne Schindler, WashU, USA
• Takeshi Iwatsubo, UTokyo, Japan
• Tamara Shiner, TASMC, TAU, Israel

#2 AI FOR NEURODEGENERATIVE DISEASE RESEARCH

• Xiao Wang, MIT, USA
• Keith Hengen, WashU, USA
• TBD
• TBD

SCIENTIFIC COMMITTEE

• Kristine Freude, UCPH, Denmark
• Per Nilsson, KI, Sweden
• Julia TCW, BU, USA
• Hui (Iris) Zhang, UGA, USA



August 25-26, 2025

8:30 AM – 2:00 PM ET



Abstract Deadline

June 23, 2025
(Max 2 Submissions/ Person)



Fee

Member: Free
Non-Member: $50

MEMBER Registration & Abstract Submission

NON-MEMBER Registration & Abstract Submission

The International Society for Molecular Neurodegeneration, or ISMND, is a nonprofit organization that serves as an accelerator for the continuous improvement of brain and eye health and well-being by creating a multidisciplinary global platform for scientists, physicians, and the public from different facets and scientific disciplines to more readily connect, share and communicate scientific discoveries, and develop cures for neurodegenerative diseases, in the hopes of a world free of brain and eye diseases.

Welcome to ISMND!

As the Founder and current President of the International Society for Molecular Neurodegeneration (ISMND), it is with great joy that we welcome you to our website. The concept of ISMND was spurred by our passion for science community and many years of experience from research in the field of Molecular Neurodegeneration. ISMND was born in the early stages of the COVID-19 pandemic, a time during which promoting alternative ways for people around the world to interact and stay connected had never been more important. With the creation of ISMND, we want to cultivate an inclusive and diverse place for all like minds to share creative ideas and experiences, as well as to provide helpful services for scientists in the field of Molecular Neurodegeneration.

Our mission is to connect investigators and to share scientific discoveries while helping with training the next generation of scientists. It is our wish to promote healthy brain aging and promote the development of effective and innovative therapeutics ultimately to prevent and cure neurodegenerative and eye diseases.

We sincerely hope that you will join our community and find this platform as a source of inspiration and help in advancing scientific careers for many years to come.